You can buy or sell EIGR and other stocks, options, ETFs, and crypto commission-free!
Eiger BioPharmaceuticals, Inc. Common Stock, also called Eiger BioPharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It focuses on the development and commercialization of well-characterized drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.
Palo Alto, California
52 Week High
52 Week Low
Yahoo FinanceApr 26
Do Institutions Own Shares In Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)?
A look at the shareholders of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. We also tend to see lower insider ownership in companies that were previously publicly owned. Eiger BioPharmaceuticals is a smaller company with a market capitalization of US$267m, so it may still be flying under the radar of many institutional investors. Taking a l...
-$0.95 per share
-$0.90 per share